AKT1 and colorectal carcinoma: The upregulation of miR-135b and miR-182 directly targets ST6GALNAC2 via the phosphoinositide 3-kinase/protein kinase B (PI3K)/AKT signalling pathway, enhancing chemoresistance in CRC [21].